Carregant...
Tackling breast cancer chemoresistance with nano-formulated siRNA
Breast cancer is the leading cancer diagnosed in women and the second leading cause of cancer-related deaths in women. Current limitations to standard chemotherapy in the clinic are extensively researched, including problems arising from repeated treatments with the same drugs. The phenomenon that c...
Guardat en:
| Publicat a: | Gene Ther |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5540231/ https://ncbi.nlm.nih.gov/pubmed/27648580 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/gt.2016.67 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|